Published in Cancer on November 01, 2006
Value of symptoms and additional diagnostic tests for colorectal cancer in primary care: systematic review and meta-analysis. BMJ (2010) 2.94
Stool DNA and occult blood testing for screen detection of colorectal neoplasia. Ann Intern Med (2008) 2.74
Effectiveness of fecal immunochemical testing in reducing colorectal cancer mortality from the One Million Taiwanese Screening Program. Cancer (2015) 2.19
Screening for colorectal cancer: random comparison of guaiac and immunochemical faecal occult blood testing at different cut-off levels. Br J Cancer (2009) 1.93
Korean guidelines for colorectal cancer screening and polyp detection. Clin Endosc (2012) 1.25
Systems of support to increase colorectal cancer screening and follow-up rates (SOS): design, challenges, and baseline characteristics of trial participants. Contemp Clin Trials (2010) 1.19
Fecal Immunochemical Test Program Performance Over 4 Rounds of Annual Screening: A Retrospective Cohort Study. Ann Intern Med (2016) 1.10
Primary and secondary prevention of colorectal cancer. Clin Med Insights Gastroenterol (2014) 1.07
Potential of soluble CD26 as a serum marker for colorectal cancer detection. World J Clin Oncol (2011) 1.04
Evaluation of a home-based colorectal cancer screening intervention in a rural state. J Rural Health (2013) 0.99
Colorectal cancer screening: tests, strategies, and perspectives. Front Public Health (2014) 0.99
Uptake and positive predictive value of fecal occult blood tests: A randomized controlled trial. Prev Med (2013) 0.97
Fecal immunochemical test accuracy in average-risk colorectal cancer screening. World J Gastroenterol (2014) 0.96
Increasing colorectal cancer screening in an overdue population: participation and cost impacts of adding telephone calls to a FIT mailing program. J Community Health (2014) 0.94
Impact of Screening Program on Incidence of Colorectal Cancer: A Cohort Study in Italy. Am J Gastroenterol (2015) 0.89
Implementation intentions and colorectal screening: a randomized trial in safety-net clinics. Am J Prev Med (2014) 0.88
Cost-effectiveness of colorectal cancer screening - an overview. Best Pract Res Clin Gastroenterol (2010) 0.88
Implications of new colorectal cancer screening technologies for primary care practice. Med Care (2008) 0.87
Population-based colorectal cancer screening: comparison of two fecal occult blood test. Front Pharmacol (2014) 0.86
Recommendations on Fecal Immunochemical Testing to Screen for Colorectal Neoplasia: A Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer. Am J Gastroenterol (2016) 0.85
Guaiac based faecal occult blood testing for colorectal cancer screening: an obsolete strategy? Gut (2012) 0.84
Effect of verification bias on the sensitivity of fecal occult blood testing: a meta-analysis. J Gen Intern Med (2010) 0.82
Colorectal cancer screening in an equal access healthcare system. J Cancer (2013) 0.80
Diagnostic accuracy of fecal immunochemical test in average- and familial-risk colorectal cancer screening. United European Gastroenterol J (2014) 0.80
Fecal immunochemical tests for colorectal cancer screening: a systematic review of accuracy and compliance. CADTH Technol Overv (2010) 0.80
Which fecal occult blood test is best to screen for colorectal cancer? Nat Clin Pract Gastroenterol Hepatol (2009) 0.80
Fecal Tests: From Blood to Molecular Markers. Curr Colorectal Cancer Rep (2011) 0.79
A Blood Test for Methylated BCAT1 and IKZF1 vs. a Fecal Immunochemical Test for Detection of Colorectal Neoplasia. Clin Transl Gastroenterol (2016) 0.78
The sensitivity, specificity, predictive values, and likelihood ratios of fecal occult blood test for the detection of colorectal cancer in hospital settings. Clin Exp Gastroenterol (2015) 0.78
New faecal tests for colorectal cancer screening: is tumour pyruvate kinase M2 one of the options? Br J Cancer (2007) 0.77
Recommendations for a step-wise comparative approach to the evaluation of new screening tests for colorectal cancer. Cancer (2016) 0.76
Evaluating an Electronic Measure of Colorectal Cancer Screening at Indian Health Service Facilities, 2008-2010. IHS Prim Care Provid (2014) 0.75
Assessing the effectiveness of a cancer screening test in the presence of another screening modality. J Med Screen (2014) 0.75
Comparison of a brush-sampling fecal immunochemical test for hemoglobin with a sensitive guaiac-based fecal occult blood test in detection of colorectal neoplasia. Cancer (2007) 0.75
Detection of fecal interferon-induced transmembrane protein messenger RNA for colorectal cancer screening. Oncol Lett (2010) 0.75
Timing and Risk Factors for a Positive Fecal Immunochemical Test in Subsequent Screening for Colorectal Neoplasms. PLoS One (2015) 0.75
Comparison of fecal occult blood tests for colorectal cancer screening in an Alaska Native population with high prevalence of Helicobacter pylori infection, 2008-2012. Prev Chronic Dis (2014) 0.75
The effectiveness of FOBT vs. FIT: A meta-analysis on colorectal cancer screening test. Med J Islam Repub Iran (2016) 0.75
Characteristics of colorectal tumours in asymptomatic patients with negative immunochemical faecal occult blood test results. Mol Clin Oncol (2015) 0.75
Knowledge and perception toward colorectal cancer screening in east of Iran. Int J Health Policy Manag (2014) 0.75
Screening for colorectal cancer using a quantitative immunochemical faecal occult blood test: a feasibility study in an Asian population. Tech Coloproctol (2009) 0.75
Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol Cancer Res (2003) 17.13
Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies. Lancet (2009) 14.01
Overadjustment bias and unnecessary adjustment in epidemiologic studies. Epidemiology (2009) 9.00
Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the multicenter AIDS cohort study. Arch Intern Med (2005) 6.02
Competing risk regression models for epidemiologic data. Am J Epidemiol (2009) 4.75
Impact of HIV infection and HAART on serum lipids in men. JAMA (2003) 4.01
Design and methods of the Chronic Kidney Disease in Children (CKiD) prospective cohort study. Clin J Am Soc Nephrol (2006) 3.84
Use of multiple imputation in the epidemiologic literature. Am J Epidemiol (2008) 3.76
A meta-analysis of the incidence of non-AIDS cancers in HIV-infected individuals. J Acquir Immune Defic Syndr (2009) 3.76
Structural accelerated failure time models for survival analysis in studies with time-varying treatments. Pharmacoepidemiol Drug Saf (2005) 3.05
Intrinsic breast tumor subtypes, race, and long-term survival in the Carolina Breast Cancer Study. Clin Cancer Res (2010) 3.04
Racial disparities in HIV virologic failure: do missed visits matter? J Acquir Immune Defic Syndr (2009) 2.58
Development of a quality-of-life questionnaire for adults with strabismus. Ophthalmology (2008) 2.46
Bivariate meta-analysis of sensitivity and specificity with sparse data: a generalized linear mixed model approach. J Clin Epidemiol (2006) 2.45
Risks of primary extracolonic cancers following colorectal cancer in lynch syndrome. J Natl Cancer Inst (2012) 2.44
Invited commentary: positivity in practice. Am J Epidemiol (2010) 2.33
Metachronous colorectal cancer risk for mismatch repair gene mutation carriers: the advantage of more extensive colon surgery. Gut (2010) 2.30
Postnatal HIV-1 transmission after cessation of infant extended antiretroviral prophylaxis and effect of maternal highly active antiretroviral therapy. J Infect Dis (2009) 2.26
Colorectal and other cancer risks for carriers and noncarriers from families with a DNA mismatch repair gene mutation: a prospective cohort study. J Clin Oncol (2012) 2.22
Antiretroviral therapy exposure and incidence of diabetes mellitus in the Women's Interagency HIV Study. AIDS (2007) 2.10
Missing doses in the life span study of Japanese atomic bomb survivors. Am J Epidemiol (2013) 2.08
Neighborhood poverty and injection cessation in a sample of injection drug users. Am J Epidemiol (2010) 2.07
The effect of highly active antiretroviral therapy on the survival of HIV-infected children in a resource-deprived setting: a cohort study. PLoS Med (2011) 2.06
Invited Commentary: Causal diagrams and measurement bias. Am J Epidemiol (2009) 2.06
Use of a marginal structural model to determine the effect of aspirin on cardiovascular mortality in the Physicians' Health Study. Am J Epidemiol (2002) 2.02
Effect on mortality and virological response of delaying antiretroviral therapy initiation in children receiving tuberculosis treatment. AIDS (2010) 1.99
Association of proteinuria with race, cause of chronic kidney disease, and glomerular filtration rate in the chronic kidney disease in children study. Clin J Am Soc Nephrol (2009) 1.98
Temporal trends in presentation and survival for HIV-associated lymphoma in the antiretroviral therapy era. J Natl Cancer Inst (2013) 1.96
Incidence of lipoatrophy and lipohypertrophy in the women's interagency HIV study. J Acquir Immune Defic Syndr (2003) 1.95
Viremia copy-years predicts mortality among treatment-naive HIV-infected patients initiating antiretroviral therapy. Clin Infect Dis (2011) 1.91
A proposal to standardize reporting units for fecal immunochemical tests for hemoglobin. J Natl Cancer Inst (2012) 1.83
Interval fecal immunochemical testing in a colonoscopic surveillance program speeds detection of colorectal neoplasia. Gastroenterology (2010) 1.74
Shift to earlier stage at diagnosis as a consequence of the National Bowel Cancer Screening Program. Med J Aust (2013) 1.73
Comparison of quality-of-life instruments in adults with strabismus. Am J Ophthalmol (2009) 1.73
Inverse probability-of-censoring weights for the correction of time-varying noncompliance in the effect of randomized highly active antiretroviral therapy on incident AIDS or death. Stat Med (2009) 1.73
Applying evidence-based guidelines improves use of colonoscopy resources in patients with a moderate risk of colorectal neoplasia. Med J Aust (2002) 1.73
The association of HIV susceptibility testing with survival among HIV-infected patients receiving antiretroviral therapy: a cohort study. Ann Intern Med (2009) 1.69
Splines for trend analysis and continuous confounder control. Epidemiology (2011) 1.69
A systematic review and meta-regression of temporal trends in adult CD4(+) cell count at presentation to HIV care, 1992-2011. Clin Infect Dis (2013) 1.67
An information criterion for marginal structural models. Stat Med (2012) 1.65
Influenza vaccine effectiveness in patients on hemodialysis: an analysis of a natural experiment. Arch Intern Med (2012) 1.64
The parametric g-formula to estimate the effect of highly active antiretroviral therapy on incident AIDS or death. Stat Med (2012) 1.63
Linear regression with an independent variable subject to a detection limit. Epidemiology (2010) 1.61
A comparison of methods to estimate the hazard ratio under conditions of time-varying confounding and nonpositivity. Epidemiology (2011) 1.59
Risk of amblyopia recurrence after cessation of treatment. J AAPOS (2004) 1.59
The effect of HIV infection on overdose mortality. AIDS (2005) 1.58
Enrollment, retention, and visit attendance in the University of North Carolina Center for AIDS Research HIV clinical cohort, 2001-2007. AIDS Res Hum Retroviruses (2010) 1.58
Impact of patching and atropine treatment on the child and family in the amblyopia treatment study. Arch Ophthalmol (2003) 1.56
Cancer risks for MLH1 and MSH2 mutation carriers. Hum Mutat (2013) 1.55
Performance of rapid influenza H1N1 diagnostic tests: a meta-analysis. Influenza Other Respir Viruses (2011) 1.55
Sodium intake from various time frames and incident hypertension among Chinese adults. Epidemiology (2013) 1.55
Mortality after cancer diagnosis in HIV-infected individuals treated with antiretroviral therapy. AIDS (2011) 1.52
Regression models for the effects of exposure rate and cumulative exposure. Epidemiology (2012) 1.50
Time at risk and intention-to-treat analyses: parallels and implications for inference. Epidemiology (2015) 1.47
The role of the c-statistic in variable selection for propensity score models. Pharmacoepidemiol Drug Saf (2010) 1.45
Evaluation of oral rehydration solution by whole-gut perfusion in rats: effect of osmolarity, sodium concentration and resistant starch. J Pediatr Gastroenterol Nutr (2006) 1.41
Development and initial validation of quality-of-life questionnaires for intermittent exotropia. Ophthalmology (2009) 1.40
Immortal person-time in studies of cancer outcomes. J Clin Oncol (2009) 1.40
Mannose-binding lectin deficiency does not increase the prevalence of Helicobacter pylori seropositivity. Eur J Gastroenterol Hepatol (2007) 1.38
Time scale and adjusted survival curves for marginal structural cox models. Am J Epidemiol (2010) 1.36
Shared and unique contributions of anger, anxiety, and depression to coronary heart disease: a prospective study in the normative aging study. Ann Behav Med (2006) 1.33
Lung cancer incidence and mortality among HIV-infected and HIV-uninfected injection drug users. J Acquir Immune Defic Syndr (2010) 1.33
Incidence and timing of cancer in HIV-infected individuals following initiation of combination antiretroviral therapy. Clin Infect Dis (2013) 1.31
Sensitivity analysis of misclassification: a graphical and a Bayesian approach. Ann Epidemiol (2006) 1.30
Colorectal Neoplasia Differentially Expressed (CRNDE), a Novel Gene with Elevated Expression in Colorectal Adenomas and Adenocarcinomas. Genes Cancer (2011) 1.28
Phenotypic diversity in patients with multiple serrated polyps: a genetics clinic study. Int J Colorectal Dis (2010) 1.27
Anthropometrics and examiner-reported body habitus abnormalities in the multicenter AIDS cohort study. Clin Infect Dis (2004) 1.27
Joint effects of alcohol consumption and high-risk sexual behavior on HIV seroconversion among men who have sex with men. AIDS (2013) 1.27
A panel of genes methylated with high frequency in colorectal cancer. BMC Cancer (2014) 1.26
Protocol for population testing of an Internet-based Personalised Decision Support system for colorectal cancer screening. BMC Med Inform Decis Mak (2010) 1.24
Time-modified confounding. Am J Epidemiol (2009) 1.24
Antiretroviral therapy exposure and insulin resistance in the Women's Interagency HIV study. J Acquir Immune Defic Syndr (2008) 1.22
Hierarchical regression for analyses of multiple outcomes. Am J Epidemiol (2015) 1.22
Meta-analysis of diagnostic accuracy studies accounting for disease prevalence: alternative parameterizations and model selection. Stat Med (2009) 1.22
The parametric g-formula for time-to-event data: intuition and a worked example. Epidemiology (2014) 1.22
Fear and fertility in inflammatory bowel disease: a mismatch of perception and reality affects family planning decisions. Inflamm Bowel Dis (2009) 1.20
Effect of discontinuing antiretroviral therapy on survival of women initiated on highly active antiretroviral therapy. AIDS (2004) 1.18
Psychosocial variables associated with colorectal cancer screening in South Australia. Int J Behav Med (2011) 1.17
Prevalence and predictors of metabolic syndrome among HIV-infected and HIV-uninfected women in the Women's Interagency HIV Study. J Acquir Immune Defic Syndr (2008) 1.17
Effect of tuberculosis on the survival of HIV-infected men in a country with low tuberculosis incidence. AIDS (2008) 1.16
Longitudinal trends in hazardous alcohol consumption among women with human immunodeficiency virus infection, 1995-2006. Am J Epidemiol (2009) 1.16
Analysis of occupational asbestos exposure and lung cancer mortality using the g formula. Am J Epidemiol (2013) 1.15
Short-term discontinuation of HAART regimens more common in vulnerable patient populations. AIDS Res Hum Retroviruses (2008) 1.15
Further validation of the Amblyopia Treatment Index parental questionnaire. J AAPOS (2008) 1.14
Pregnancy and virologic response to antiretroviral therapy in South Africa. PLoS One (2011) 1.14
Human gastrointestinal neoplasia-associated myofibroblasts can develop from bone marrow-derived cells following allogeneic stem cell transplantation. Stem Cells (2009) 1.14
Association of germline microRNA SNPs in pre-miRNA flanking region and breast cancer risk and survival: the Carolina Breast Cancer Study. Cancer Causes Control (2013) 1.13
Effect of high amylose maize starches on colonic fermentation and apoptotic response to DNA-damage in the colon of rats. Nutr Metab (Lond) (2009) 1.13
Effect of highly active antiretroviral therapy on multiple AIDS-defining illnesses among male HIV seroconverters. Am J Epidemiol (2005) 1.12
Hemoglobin decline in children with chronic kidney disease: baseline results from the chronic kidney disease in children prospective cohort study. Clin J Am Soc Nephrol (2008) 1.11
Sexually transmitted infections and prostatic inflammation/cell damage as measured by serum prostate specific antigen concentration. J Urol (2006) 1.11
Map of differential transcript expression in the normal human large intestine. Physiol Genomics (2007) 1.11
Effect of highly active antiretroviral therapy on incident AIDS using calendar period as an instrumental variable. Am J Epidemiol (2009) 1.09
A simulation study of control sampling methods for nested case-control studies of genetic and molecular biomarkers and prostate cancer progression. Cancer Epidemiol Biomarkers Prev (2009) 1.08
Accounting for misclassified outcomes in binary regression models using multiple imputation with internal validation data. Am J Epidemiol (2013) 1.06